These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31692076)

  • 21. Outcome measurement of extensive implementation of antimicrobial stewardship in patients receiving intravenous antibiotics in a Japanese university hospital.
    Niwa T; Shinoda Y; Suzuki A; Ohmori T; Yasuda M; Ohta H; Fukao A; Kitaichi K; Matsuura K; Sugiyama T; Murakami N; Itoh Y
    Int J Clin Pract; 2012 Oct; 66(10):999-1008. PubMed ID: 22846073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent initiatives to reduce the spread of meticillin-resistant Staphylococcus aureus.
    Wilcox MH
    Br J Hosp Med (Lond); 2009 Jul; 70(7):399-401. PubMed ID: 19584782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.
    Gould IM; Reilly J; Bunyan D; Walker A
    Clin Microbiol Infect; 2010 Dec; 16(12):1721-8. PubMed ID: 20825434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis.
    Chaberny IF; Schwab F; Ziesing S; Suerbaum S; Gastmeier P
    J Antimicrob Chemother; 2008 Dec; 62(6):1422-9. PubMed ID: 18765411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers.
    Rodríguez-Baño J; García L; Ramírez E; Lupión C; Muniain MA; Velasco C; Gálvez J; del Toro MD; Millán AB; López-Cerero L; Pascual A
    Infect Control Hosp Epidemiol; 2010 Aug; 31(8):786-95. PubMed ID: 20524852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-benefit of infection control interventions targeting methicillin-resistant Staphylococcus aureus in hospitals: systematic review.
    Farbman L; Avni T; Rubinovitch B; Leibovici L; Paul M
    Clin Microbiol Infect; 2013 Dec; 19(12):E582-93. PubMed ID: 23991635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Search and destroy policy for methicillin-resistant Staphylococcus aureus: cost-benefit analysis.
    Simoens S; Ophals E; Schuermans A
    J Adv Nurs; 2009 Sep; 65(9):1853-9. PubMed ID: 19694848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later.
    Jernigan JA; Clemence MA; Stott GA; Titus MG; Alexander CH; Palumbo CM; Farr BM
    Infect Control Hosp Epidemiol; 1995 Dec; 16(12):686-96. PubMed ID: 8683086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of meticillin-resistant Staphylococcus aureus bloodstream infections in European hospitals: moving beyond policies.
    Borg MA; Hulscher M; Scicluna EA; Richards J; Azanowsky JM; Xuereb D; Huis A; Moro ML; Maltezou HC; Frank U
    J Hosp Infect; 2014 Aug; 87(4):203-11. PubMed ID: 24973016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New threats to the control of methicillin-resistant Staphylococcus aureus.
    Casewell MW
    J Hosp Infect; 1995 Jun; 30 Suppl():465-71. PubMed ID: 7560985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of daily chlorhexidine bathing on the acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit with methicillin-resistant S aureus endemicity.
    Kim JS; Chung YK; Lee SS; Lee JA; Kim HS; Park EY; Shin KS; Kang BS; Lee HJ; Kang HJ
    Am J Infect Control; 2016 Dec; 44(12):1520-1525. PubMed ID: 27520786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-series analysis of the relationship of antimicrobial use and hand hygiene promotion with the incidence of healthcare-associated infections.
    Lee YT; Chen SC; Lee MC; Hung HC; Huang HJ; Lin HC; Wu DJ; Tsao SM
    J Antibiot (Tokyo); 2012 Jun; 65(6):311-6. PubMed ID: 22569161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.
    Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S
    BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of a "search and destroy" strategy for the prevention of methicillin-resistant Staphylococcus aureus infections in an inpatient rehabilitation facility.
    Widner A; Nobles DL; Faulk C; Vos P; Ramsey KM
    PM R; 2014 Feb; 6(2):121-6; quiz 126. PubMed ID: 24107426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of a major epidemic of methicillin-resistant Staphylococcus aureus: the costs of screening and consequences of outbreak management.
    van der Zee A; Hendriks WD; Roorda L; Ossewaarde JM; Buitenwerf J
    Am J Infect Control; 2013 Mar; 41(3):204-9. PubMed ID: 22921104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs of endemic MRSA.
    Bowler IC; Storr JA
    J Hosp Infect; 1998 Oct; 40(2):159. PubMed ID: 9819696
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality and medical cost: a quasi-experimental study in surgical intensive care unit.
    Lee YJ; Chen JZ; Lin HC; Liu HY; Lin SY; Lin HH; Fang CT; Hsueh PR
    Crit Care; 2015 Apr; 19(1):143. PubMed ID: 25882709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
    Kim T; Oh PI; Simor AE
    Infect Control Hosp Epidemiol; 2001 Feb; 22(2):99-104. PubMed ID: 11232886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Survey of methicillin-resistant Staphylococcus aureus control measures in hospitals participating in the VINCat program].
    Sopena-Galindo N; Hornero-Lopez A; Freixas-Sala N; Bella-Cueto F; Pérez-Jové J; Limon-Cáceres E; Gudiol-Munté F;
    Enferm Infecc Microbiol Clin; 2016; 34(7):409-14. PubMed ID: 26589755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network.
    Anderson DJ; Miller BA; Chen LF; Adcock LH; Cook E; Cromer AL; Louis S; Thacker PA; Sexton DJ
    Infect Control Hosp Epidemiol; 2011 Apr; 32(4):315-22. PubMed ID: 21460482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.